Use of the Carlino Technique in Chronic Total Occlusion Percutaneous Coronary Intervention.


Journal

The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277

Informations de publication

Date de publication:
15 11 2023
Historique:
received: 17 07 2023
revised: 22 08 2023
accepted: 23 08 2023
medline: 6 11 2023
pubmed: 30 9 2023
entrez: 29 9 2023
Statut: ppublish

Résumé

We examined the outcomes of the Carlino technique in chronic total occlusion (CTO) percutaneous coronary interventions (PCIs). We analyzed the baseline clinical and angiographic characteristics and outcomes of 128 CTO PCIs that included the Carlino technique at 22 US and no-US centers between 2016 and 2023. The Carlino technique was used in 128 (2.8%) of 4,508 cases that used anterograde dissection and reentry (78.9%) or the retrograde approach (21.1%) during the study period, and it increased steadily over time (from 0.0% in 2016 to 8.3% in 2023). The mean patient age was 65.6 ± 9.7 years, and 88.7% of the patients were men with high prevalence of hypertension (89.1%) and dyslipidemia (80.2%). The Carlino technique was more commonly used in cases with moderate to severe calcification (77.2% vs 55.5%, p <0.001) with higher J-CTO (3.3 ± 0.9 vs 3.0 ± 1.1, p = 0.007), Prospective Global Registry for the Study of Chronic Total Occlusion Intervention (PROGRESS-CTO) (1.7 ± 1.0 vs 1.4 ± 1.0, p = 0.001), PROGRESS-CTO Mortality (2.6 ± 0.9 vs 2.0 ± 0.9, p = 0.013) and PROGRESS-CTO Perforation (3.7 ± 1.1 vs 3.5 ± 1.0, p = 0.029) scores. Carlino cases had longer procedure and fluoroscopy time, and higher contrast volume and radiation dose. Carlino cases had lower technical (65.6% vs 78.5%, p <0.001) and procedural (63.3% vs 76.3%, p <0.001) success, similar major adverse cardiac events (6.2% vs 3.2%, p = 0.101) and higher incidence of pericardiocentesis (3.9% vs 1.3%, p = 0.042), perforation (18.0% vs 8.9%, p = 0.001) and contrast-induced acute kidney injury (2.3% vs 0.4%, p = 0.012). The Carlino technique was associated with higher procedural success when used for retrograde crossing (81.5% vs 58.4%, p = 0.047). The Carlino technique is increasingly being used in CTO PCI especially for higher complexity lesions.

Identifiants

pubmed: 37774471
pii: S0002-9149(23)00936-0
doi: 10.1016/j.amjcard.2023.08.155
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

305-313

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors have no competing interests to declare.

Auteurs

Michaella Alexandrou (M)

Center of Coronary Artery Disease, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota.

Athanasios Rempakos (A)

Center of Coronary Artery Disease, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota.

Ahmed Al Ogaili (A)

Center of Coronary Artery Disease, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota.

James W Choi (JW)

Department of Cardiology, Texas Health Presbyterian Hospital, Dallas, Texas.

Paul Poommipanit (P)

Section of Cardiology, University Hospitals, Case Western Reserve University, Cleveland, Ohio.

Jaikirshan J Khatri (JJ)

Department of Cardiovascular medicine, Cleveland Clinic, Cleveland, Ohio.

Basem Elbarouni (B)

Department of Internal Medicine, St. Boniface General Hospital, Winnipeg, Manitoba, Canada.

Michael P Love (MP)

Department of Internal Medicine, St. Boniface General Hospital, Winnipeg, Manitoba, Canada.

Wissam Jaber (W)

Division of Cardiology, Emory University Hospital Midtown, Atlanta, Georgia.

Stephane Rinfret (S)

Division of Cardiology, Emory University Hospital Midtown, Atlanta, Georgia.

William Nicholson (W)

Division of Cardiology, Emory University Hospital Midtown, Atlanta, Georgia.

Raj Chandwaney (R)

Department of Invasive Cardiology, Oklahoma Heart Institute, Tulsa, Oklahoma.

Lorenzo Azzalini (L)

Division of Cardiology, Department of Medicine, University of Washington, Seattle, Washington.

Kathleen E Kearney (KE)

Division of Cardiology, Department of Medicine, University of Washington, Seattle, Washington.

Ahmed M ElGuindy (AM)

Aswan Heart Center, Department of Cardiology, Magdi Yacoub Foundation, Cairo, Egypt.

Nidal Abi Rafeh (N)

Department of Cardiology, North Oaks Health System, Hammond, Louisiana.

Oleg Krestyaninov (O)

Department of Invasive Cardiology, Meshalkin Novosibirsk Research Institute, Novosibirsk, Russian Federation.

Dmitrii Khelimskii (D)

Department of Invasive Cardiology, Meshalkin Novosibirsk Research Institute, Novosibirsk, Russian Federation.

Omer Goktekin (O)

Department of Cardiology, Memorial Bahcelievler Hospital, Istanbul, Turkey.

Sevket Gorgulu (S)

Department of Cardiology, Biruni University Medical School, Istanbul, Turkey.

Mauro Carlino (M)

Interventional Cardiology Division, Cardio-Thoracic-Vascular Department, San Raffaele Scientific Institute, Milan, Italy.

Luiz F Ybarra (LF)

Department of Cardiology, London Health Sciences Center, Western University, London, Ontario, Canada.

Jarrod D Frizzell (JD)

Department of Cardiology, St. Vincent Hospital, Indianapolis, Indiana.

Bavana V Rangan (BV)

Center of Coronary Artery Disease, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota.

Olga C Mastrodemos (OC)

Center of Coronary Artery Disease, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota.

Yader Sandoval (Y)

Center of Coronary Artery Disease, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota.

M Nicholas Burke (MN)

Center of Coronary Artery Disease, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota.

Emmanouil S Brilakis (ES)

Center of Coronary Artery Disease, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota. Electronic address: esbrilakis@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH